[The bionic heart patient: care about aftercare]

Martin J Schalij1

  • 1Leids Universitair Medisch Centrum, afd. Hartziekten, Leiden.

Insights

Advances in cardiac care, including implantable cardioverter defibrillators (ICDs) and percutaneous valve interventions, improve patient outcomes. However, these life-saving procedures carry risks, necessitating careful patient selection and follow-up for optimal results.

Area of Science:

  • Cardiology and Cardiovascular Interventions
  • Medical Device Technology
  • Patient Outcomes Research

Background:

  • Significant advancements in cardiovascular disorder management over recent decades.
  • Improved prognosis for many heart patients due to new diagnostic and therapeutic options.
  • Introduction of implantable cardioverter defibrillators (ICDs) and resynchronization therapy.

Purpose of the Study:

  • To review the benefits and risks of modern cardiovascular interventions.
  • To highlight the impact of devices like ICDs and percutaneous valve procedures.
  • To emphasize the importance of patient selection and follow-up in cardiac care.

Main Methods:

  • Review of recent advancements in cardiac patient care.
  • Analysis of the efficacy of implantable cardioverter defibrillators (ICDs) and resynchronization therapy.
  • Evaluation of percutaneous valve implantation and repair techniques.

Main Results:

  • ICDs and resynchronization therapy reduce sudden death from ventricular arrhythmias and improve heart failure symptoms.
  • Percutaneous valve interventions offer improved prognosis for inoperable patients.
  • Interventions are associated with risks including severe complications like infection, perforation, and death.

Conclusions:

  • Modern cardiac interventions significantly improve patient prognosis but carry inherent risks.
  • Long-term complications from device infections or failures remain a concern.
  • Mandatory multi-disciplinary patient selection and extensive follow-up are crucial for successful outcomes.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
630
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
481